Mereo BioPharma Group PLC logo

Mereo BioPharma Group PLC - ADR

NEW
NAS:MREO (UK)   ADR
$ 2.4 -0.050 (-2.04%) 12:08 AM EST
At Loss
P/B:
5.24
Market Cap:
$ 372.35M
Enterprise V:
$ 298.51M
Volume:
1.89M
Avg Vol (2M):
1.25M
Trade In:
Volume:
1.89M
At Loss
Avg Vol (2M):
1.25M

Business Description

Description
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
Name Current Vs Industry Vs History
Cash-To-Debt 12.05
Equity-to-Asset 0.82
Debt-to-Equity 0.09
Debt-to-EBITDA -0.15
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.93
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 6.35
9-Day RSI 16.73
14-Day RSI 25
3-1 Month Momentum % -16.5
6-1 Month Momentum % -35.82
12-1 Month Momentum % -20.79

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.1
Quick Ratio 6.1
Cash Ratio 5.67
Days Sales Outstanding 3633.58

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -27.5
Shareholder Yield % 1.97

Financials (Next Earnings Date:2025-03-27 Est.)

MREO's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MREO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Mereo BioPharma Group PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1
EPS (TTM) ($) -0.3
Beta -
3-Year Sharpe Ratio 0.63
3-Year Sortino Ratio 1.61
Volatility % 43
14-Day RSI 25
14-Day ATR ($) 0.171076
20-Day SMA ($) 2.8855
12-1 Month Momentum % -20.79
52-Week Range ($) 2.37 - 5.02
Shares Outstanding (Mil) 155.15

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Mereo BioPharma Group PLC Filings

Filing Date Document Date Form
No Filing Data

Mereo BioPharma Group PLC Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Mereo BioPharma Group PLC Frequently Asked Questions

What is Mereo BioPharma Group PLC(MREO)'s stock price today?
The current price of MREO is $2.40. The 52 week high of MREO is $5.02 and 52 week low is $2.37.
When is next earnings date of Mereo BioPharma Group PLC(MREO)?
The next earnings date of Mereo BioPharma Group PLC(MREO) is 2025-03-27 Est..
Does Mereo BioPharma Group PLC(MREO) pay dividends? If so, how much?
Mereo BioPharma Group PLC(MREO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1